Ryan Genkin

Ryan focuses on M&A and other complex corporate transactions and governance matters. He has experience advising strategic and private equity clients on their most complex, high-stakes matters, including cross-border public and private M&A, spinoff transactions, joint ventures, de-SPAC transactions, growth equity investments, and offerings of debt and equity securities.

Ryan has advised clients on bet-the-company transactions across a range of industries, including tech, consumer packaged goods, retail, real estate, defense, mining, wealth management, automotive, artificial intelligence, fintech, healthcare, medical devices and pharmaceuticals.

Before joining Cooley, Ryan was a member of the corporate department focusing on M&A at a prominent New York City law firm. While at Northwestern Law, he won the 2017 National Championship for Startup LawMeet. Before pursuing his law career, he was a strategy consultant at Accenture Strategy.

Ryan’s notable transactions include representing:

• Neurocrine Biosciences in its $2.9 billion acquisition of Soleno Therapeutics
• Candid Therapeutics in its agreed merger with Rallybio and concurrent private financing of $505 million
• IQM Finland, a global leader in full-stack superconducting quantum computers, in its combination with Real Asset Acquisition Corp., valuing IQM at a pre-money equity value of $1.8 billion
• Observe, a top artificial intelligence-powered observability platform, in its sale to Snowflake
• Adverum Biotechnologies in its up to $350 million acquisition by Eli Lilly and Company
• Y-mAbs Therapeutics in its $412 million acquisition by SERB Pharmaceuticals
• Just Eat Takeaway.com in its $7.3 billion acquisition of Grubhub and its initial listing on Nasdaq*
• Peugeot in its $50 billion merger with Fiat Chrysler to form Stellantis*
• Iris Financial, a Euronext Amsterdam‑listed special purpose acquisition company (SPAC) sponsored by Ripplewood Holdings, in its combination with Younited to form a new consumer credit business*
• International Business Machines (IBM) in its $4 billion aggregate registered notes offering*
• OMERS Private Equity in its acquisition of a majority stake in Knight Commercial*
• Amentum in its Reverse Morris Trust merger with Jacobs’ Critical Mission Solutions and Cyber & Intelligence businesses, creating a combined organization with $13 billion in revenue*
• Neuberger Berman in its significant investment in Mariner*
• The underwriters in connection with an equity offering for Callaway Golf*

* Representation handled before joining Cooley